Advertisement
Singapore markets closed
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • Dow

    38,239.98
    +253.58 (+0.67%)
     
  • Nasdaq

    15,451.31
    +169.30 (+1.11%)
     
  • Bitcoin USD

    66,169.92
    +232.26 (+0.35%)
     
  • CMC Crypto 200

    1,421.07
    +6.31 (+0.45%)
     
  • FTSE 100

    8,048.84
    +24.97 (+0.31%)
     
  • Gold

    2,308.90
    -37.50 (-1.60%)
     
  • Crude Oil

    81.96
    +0.06 (+0.07%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Bio-Rad: 4Q Earnings Snapshot

HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO) on Thursday reported fourth-quarter net income of $553.5 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Hercules, California-based company said it had profit of $18.31. Earnings, adjusted for one-time gains and costs, were $2.32 per share.

The maker of instruments used in biomedical research posted revenue of $624.4 million in the period.

For the year, the company reported profit of $1.76 billion, or $58.27 per share. Revenue was reported as $2.31 billion.

Bio-Rad shares have climbed nearly 3% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $379.85, a climb of 45% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIO at https://www.zacks.com/ap/BIO